NASDAQ:DRUG - Nasdaq - CA10919W4056 - Common Stock - Currency: USD
Overall DRUG gets a technical rating of 3 out of 10. Although DRUG is scoring some points because its good overall performance in the market in the past year, recent evolutions are not that positive. Both the medium and short term picture give negative signs.
DRUG has a poor technical rating and the quality of the setup is also only medium at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
30.10
We found 2 important support areas.
We can see 5 important resistance areas.
34.1
+0.6 (+1.79%)